Urology Doctors in Freeport, NY Accepting Medicare

4 Urology doctors found. Showing 1 - 4

Stanley M. Ring, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 155 W Merrick Rd, Freeport, NY 11520 Phone: 516-867-0102

Orville Wayne Mclenan, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 294 W Merrick Rd, Suite 2, Freeport, NY 11520 Phone: 516-378-0123    Fax: 516-378-0148

Daniel Mccally, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 155 W Merrick Rd Ste 204, Freeport, NY 11520 Phone: 516-867-0102    Fax: 516-867-1857

Gary Lefkowitz, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 155 W Merrick Rd, Freeport, NY 11520 Phone: 516-867-0102

News Archive

Helicobacter pylori increases risk of lower stomach cancer, decreases risk of upper

The bacteria Helicobacter pylori substantially increase the risk of cancer in the lower stomach, but it may decrease the risk of cancer near the junction between the esophagus and the stomach, according to a study in the October 19 Journal of the National Cancer Institute.

Twice-daily KALYDECO improves lung function in people with cystic fibrosis

Vertex Pharmaceuticals (Australia) Pty Ltd., announces the presentation of data from KALYDECO (ivacaftor) studies at the 10th Australasian Cystic Fibrosis Conference in Auckland, New Zealand, August 17 – 20, 2013, which further demonstrate the benefits of the medicine in people with cystic fibrosis ages 6 and older who have at least one copy of the G551D mutation in the cystic fibrosis transmembrane conductance regulator gene.

Study finds more information about how gene linked to ASD affects the brain

New preclinical research shows a gene already linked to a subset of people with autism spectrum disorder is critical to healthy neuronal connections in the developing brain, and its loss can harm those connections to help fuel the complex developmental condition.

Sorafenib with chemotherapy for breast cancer patients had a 74% percent improvement in the time they lived

One of the first of a series of trials to investigate the use of sorafenib - a targeted anti-cancer drug - for the treatment of advanced breast cancer has found that if it is combined with the chemotherapy drug, capecitabine, it makes a significant difference to the time women live without their disease worsening.

Read more Medical News

› Verified 1 days ago